Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications can reduce sexual desire and function, especially in women.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Targeting colon cancer stem cells might lead to better treatment results.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Dutasteride and finasteride affect different cell types differently.

Certain hormone treatments can improve acne and related conditions in women.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

New alopecia treatments aim for better results and fewer side effects.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

New treatments for male hypogonadism are effective and should be personalized.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Kolaviron and quercetin may help treat prostate issues.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.